Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
COVID-19 중증도 결정을 위한 혈청 SARS-CoV-2 항원
Article
[키워드] Antigen
antigenic
Antigenic assay
Chemiluminescent assay
CLIA
COVID-19
COVID-19 diagnosis
Determination
diagnostic
disease severity
evaluate
false-negative
false-negative results
followed by
help
intensive care
Kinetics
likelihood ratio
marker
N antigen
nasopharyngeal
non-severe patient
non-severe patients
onset of symptoms
Patient
performed
polymerase chain reaction
polymerase chain reactions
positive
Prognosis
prognosis test.
progression
provided
reverse transcriptase
risk
RT-PCR
RT-PCRs
SARS-CoV-2
SARS-COV-2 infection
sensitive
serum
severe and non-severe patients
severe COVID-19
severe patients
severity
Simoa
swabs
the WHO
threshold
transcriptase
Viremia
was determined
were measured
WHO Clinical Progression Scale
[DOI] 10.3390/v14081653 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v14081653 PMC 바로가기 [Article Type] Article